Trastuzumab Injection Market Expands with Growing Demand for Targeted HER2-Positive Cancer Therapies
The increasing prevalence of HER2-positive cancers and the growing adoption of targeted oncology treatments are driving the growth of the Trastuzumab Injection Market. Trastuzumab injection is a monoclonal antibody therapy primarily used in the treatment of HER2-positive breast cancer and gastric cancer. By specifically targeting the HER2 protein, the therapy helps slow tumor growth while...
0 Comentários 0 Compartilhamentos 21 Visualizações 0 Anterior